EFM
ORIC icon

E Fund Management’s Oric Pharmaceuticals ORIC Stock Holding History

E Fund Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Buy
+14,517
New +$165K 0.01% 455

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

E Fund Management's ORIC Position: Q1 2026 in Review

E Fund Management opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 14,517 shares worth $184K. The stake represents 0.01% of the portfolio and ranks #455 among its holdings.

182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • E Fund Management held 14,517 shares of Oric Pharmaceuticals worth $184K as of Q1 2026.
  • Oric Pharmaceuticals was a new E Fund Management position in Q1 2026.
  • Oric Pharmaceuticals made up 0.01% of E Fund Management's portfolio in Q1 2026, its #455 holding.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.